Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 103Bristol Myers Squibb

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB

Brand Name : OPDIVO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 40MG/4ML

Packaging :

Approval Date :

Application Number : 125527

Regulatory Info :

Registration Country : USA

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB

Brand Name : OPDIVO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/10ML

Packaging :

Approval Date :

Application Number : 125527

Regulatory Info :

Registration Country : USA

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB

Brand Name : OPDIVO

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 40MG/4ML

Packaging :

Approval Date :

Application Number : 125554

Regulatory Info :

Registration Country : USA

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB;RELATLIMAB-RMBW

Brand Name : OPDUALAG

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 240MG;80MG

Packaging :

Approval Date :

Application Number : 761234

Regulatory Info :

Registration Country : USA

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB;HYALURONIDASE-NVHY

Brand Name : OPDIVO QVANTIG

Dosage Form : INJECTABLE;SUBCUTANEOUS

Dosage Strength : 600MG;10000UNITS PER5ML(120MG/2000UNITS PER ML)

Packaging :

Approval Date :

Application Number : 761381

Regulatory Info :

Registration Country : USA

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB;HYALURONIDASE-NVHY

Brand Name : OPDIVO QVANTIG

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 600MG;10000 UNITS PER 5ML(120MG/2000UNITS PER ML)

Packaging :

Approval Date :

Application Number : 761429

Regulatory Info :

Registration Country : USA

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab; Relatlimab (Combination drug known as Opdualag)

Brand Name : Opdualag

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 240mg;80mg

Packaging :

Approval Date : 15/09/2022

Application Number : 20210913000057

Regulatory Info : Approved

Registration Country : Sweden

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 10mg/ml

Packaging :

Approval Date : 19/06/2015

Application Number : 20141009000029

Regulatory Info : Approved

Registration Country : Sweden

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Injectable Solution

Dosage Strength : 600mg

Packaging :

Approval Date : 26/05/2025

Application Number : 20240607000049

Regulatory Info : Approved

Registration Country : Sweden

blank

10

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Nivolumab Bms

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 10mg/ml

Packaging :

Approval Date : 20/07/2015

Application Number : 20141009000036

Regulatory Info : Deregistered

Registration Country : Sweden

blank

11

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 40mg/4ml

Packaging :

Approval Date : 30/11/2015

Application Number : 65660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

12

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 100mg/10ml

Packaging :

Approval Date : 30/11/2015

Application Number : 65660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

13

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 240mg/24ml

Packaging :

Approval Date : 30/11/2015

Application Number : 65660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

14

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form : Concentrate For Solution For Infusion

Dosage Strength : 120mg/12ml

Packaging :

Approval Date : 30/11/2015

Application Number : 65660

Regulatory Info : Allowed

Registration Country : Switzerland

blank

15

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB

Brand Name : OPDIVO

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging : 4ML

Approval Date :

Application Number : 2446626

Regulatory Info : Prescription

Registration Country : Canada

blank

16

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB

Brand Name : OPDIVO

Dosage Form : SOLUTION

Dosage Strength : 10MG/ML

Packaging : 10ML

Approval Date :

Application Number : 2446634

Regulatory Info : Prescription

Registration Country : Canada

blank

17

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

NIVOLUMAB

Brand Name : OPDUALAG

Dosage Form : SOLUTION

Dosage Strength : 240MG/20ML

Packaging :

Approval Date :

Application Number : 2541416

Regulatory Info : Prescription

Registration Country : Canada

blank

18

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

19

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

20

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Nivolumab

Brand Name : Opdivo

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank